The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hcrn GU15-215: A phase II trial of atezolizumab (atezo) and bevacizumab (bev) in cisplatin-ineligible patients (pts) with advanced/unresectable urothelial cancer (UC).
 
Arjun Vasant Balar
No Relationships to Disclose
 
Samuel Aaron Funt
No Relationships to Disclose
 
Shilpa Gupta
No Relationships to Disclose
 
Arkadiusz Z. Dudek
No Relationships to Disclose
 
Alejandro Recio Boiles
No Relationships to Disclose
 
Daniel A. Vaena
No Relationships to Disclose
 
Deepak Kilari
No Relationships to Disclose
 
Jonathan E. Rosenberg
No Relationships to Disclose